Rickettsial disease: Classical and modern aspects

New Microbiologica

Volumn 27, Issue 1, 2004, Pages 87-103

  Rizzo, M ^a   Mansueto, P ^a   Di Lorenzo, G ^a   Morselli, S ^a   Mansueto, S ^a   Rini, G B ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Boutonneuse Fever; Rickettsia; Spotted fever

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; PEFLOXACIN; TETRACYCLINE; THIAMPHENICOL;

BACTERIAL COLONIZATION; BONE MARROW TOXICITY; BOUTONNEUSE FEVER; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DRUG COST; DRUG TOLERANCE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; LABORATORY TEST; LOW DRUG DOSE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RICKETTSIA; RICKETTSIOSIS; ROCKY MOUNTAIN SPOTTED FEVER; TYPHUS; ANIMAL; CLASSIFICATION; DOG; HEALTH; MICROBIOLOGY; RAT;

BACTERIA (MICROORGANISMS); RICKETTSIA;

ANIMALS; BOUTONNEUSE FEVER; DOGS; HUMANS; RATS; RICKETTSIA; RICKETTSIA INFECTIONS; ROCKY MOUNTAIN SPOTTED FEVER; WORLD HEALTH;

EID: 1842485117     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (150)

1. ANDERSON, B.E., NEUMAN, M.A. (1997). Bartonella spp as Emerging Human Pathogens. Clinical Microbiology Reviews, 10, 203-219.
2. AOKI, N. (2000). Brill-Zinsser disease. Ryoikibetsu Shokogun Shirizu, 32, 393-394.
3. BELMAN, A.L. (1999). Tick-borne diseases. Seminars in Pediatry and Neurology, 6, 249-266.
4. BILLINGS, A.N., Yu X.J., TEEL, P.D., WALKER, D.H. (1998). Molecular characterization of a novel Rickettsia species from Ixodes scapularis in Texas. Emerging Infectious Diseases, 4, 305-309.
5. BILLINGS, A.N. (2001). Rickettsial infection in murine models activates an early anti-rickettsial effect mediated by NK cells and associated with production of gamma interferon. American Journal of Tropical Medicine and Hygiene, 65, 52-56.
6. BROUQUI, P., DUPONT, H.T., DRANCOURT, M., BOURGEADE, A., RAOULT, D. (1992). Spotless boutonneuse fever. Clinical Infectious Disease, 14, 114-116.
7. BROUQUI, P., HARLE, J.R., DELMONT, J., FRANCES, C., WEILLER, P.J., RAOULT, D. (1997). African tick-bite Fever. An imported spotless rickettsiosis. Archives of Internal Medicine, 157, 119-124.
8. BRZEZINSKI, T. (1997). The epidemic of typhus in the Polish Army in the USSR (1941-1942). Archives of Histology, Philosophy and Medicine, 62, 231-242.
9. CASANDRA, F. (1986 a). Complicanze a carico del sistema nervoso centrale in corso di FB. Acta Medica di Patologia Infettiva e Tropicale, 3, 389-395. (in italian).
10. CASANDRA, F. (1986 b). Febbre Bottonosa, due casi mortali. Acta Medica di Patologia Infettiva e Tropicale, 3, 467-473. (in italian)
11. CHIEN, R.N., LIU, N.J., LIN, P.Y., LIAW, Y.F. (1995). Granulomatous hepatitis associated with scrub typhus. Journal of Gastroenterology and Hepatology, 10, 484-487.
12. CICERONI, L., CIARROCCHI, S. (1999). Diagnosi di Laboratorio delle Rickettsiosi. Giornale Italiano di Malattie Infettive, 5, 138-144 (in italian).
13. CILLARI, E., MILANO, S., D'AGOSTINO, P., ARCOLEO, F., STASSI, G., GALLUZZO, A., RICHIUSA, P., GIORDANO, C., QUARTARARO, P., COLLETTI, P., GAMBINO, G., MOCCIARO, C., SPINELLI, A., VITALE, G., MANSUETO, S. (1996). Depression of CD4 T Cell subsets and alteration in cytokine profile in Boutonneuse Fever. Journal of Infectious Diseases, 174, 1051-1057.
14. COCUZZA, C. (1992). Spotted Fever in the Mediterranean. Journal of Medical Microbiology, 37, 133-134.
15. COMER, J.A., DIAZ, T, VLAHOV, D., MONTERROSO, E., CHILDS, J.E. (2001 a). Evidence of rodent-associated Bartonella and Rickettsia infections among intravenous drug users from Central and East Harlem, New York City. American Journal of Tropical Medicine and Hygiene, 65, 855-860.
16. COMER, J.A., VARGAS, M.C., POSHNI, I., CHILDS, J.E. (2001 b). Serologic evidence of Rickettsia akari infection among dogs in a metropolitan city. Journal of the American Veterinary Medical Association, 218, 1780-1782.
17. COWAN, G. (2000). Rickettsial diseases, the typhus group of fevers - a review. Postgraduate Medical Journal, 76, 269-272.
18. DAVI', G., GIAMMARRESI, C., VIGNERI, S., GANCI, A., FERRI, C., DI FRANCESCO, L., VITALE, G., MANSUETO, S. (1995). Demonstration of Rickettsia conorii-induced coagulative and platelet activation in vivo in patients with Mediterranean Spotted Fever. Thrombosis and Haemostasis, 74, 631-634.
19. DE LEMOS, E.R., ALVARENGA, F.B., CINTRA, M.L., RAMOS, M.C., PADDOCK, C.D., FEREBEE, T.L., ZAKI, S.R., FERREIRA, F.C., RAVAGNANI, R.C., MACHADO, R.D., GUIMARAES, M.A., COURA, J.R. (2001). Spotted fever in Brazil, a seroepidemiological study and description of clinical cases in an endemic area in the state of Sao Paulo. American Journal of Tropical Medicine and Hygien, 65, 329-334.
20. DESCAMPS, V., BOUSCARAT, F. (2001). Bartonellosis. Annales de Dermatologie et de Venereologie, 128, 669-673.
21. DRANCOURT, M., RAOULT, D., HARLE, J.R., CHAUDET, H., JANBON, F., CHARREL, C., GALLAIS, H. (1990). Biological variations in 412 patients with Mediterranean spotted fever. Annals of the New York Academy of Sciences, 590, 39-50.
22. DRANCOURT, M., GEORGE, F., BROUQUI, P., SAMPOL, J., RAOULT, D. (1992). Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads. Journal of Infectious Diseases, 166, 660-663.
23. DUJELLA, J., MOROVIC, M., DZELALIJA, B., GVERIC, M., NOVAKOVIC S. (1991). Histopathology and immunopathology of skin biopsy specimens in Mediterranean Spotted Fever. Acta Virologica, 35, 566-572.
24. DUMLER, J.S., BARBET, A.F., BEKKER, C.P., DASCH, G.A., PALMER, G.H., RAY, S.C., Rikihisa, Y., Rurangirwa, F.R. (2001). Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales, unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HE agent' as subjective synonyms of Ehrlichia phagocytophila. International Journal of Systematic and Evolutionary Microbiology, 51, 2145-2165.
25. ESMON, C.T. ( 1989). The roles of protein C and thrombomodulin in the regulation of blood coagulation. Journal of Biological Chemistry, 264, 4743-4746.
26. FENG, H., WALKER, D.H. (1993). Interferon-γ and tumor necrosis factor-α exert their antirickettsial effect via induction of synthesis of nitric oxide. American Journal of Pathology, 143, 1016-1023.
27. FENG, H., POPOV, V.L., WALKER, D.H. (1994). Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium, impairment of rickettsicidal nitric oxide production resulting in fatal., overwhelming rickettsial disease. Infection and Immunity, 62, 1952-1960.
28. FOURNIER, P.E., ROUX, V., RAOULT, D. (1998). Phylogenetic analysis of spotted fever group rickettsiae by study of the outer surface protein rOmpA. International Journal of Systematic Bacteriology, 48, 839-849.
29. FOURNIER, P.E., GRUNNENBERGER, F., JAULHAC, B., GASTINGER, G., RAOULT, D. (2000). Evidence of Rickettsia helvetica infection in humans, eastern France. Emerging Infectious Diseases, 6, 389-392.
30. GAYLE, A., RINGDAHL, E. (2001). Tick-borne diseases. American Family Physician, 64, 461-466.
31. GEORGE, F., BROUQUI, P., BOFFA, M.C., MUTIN, M., DRANCOURT, M., BRISSON, C., RAOULT, D., SAMPOL, J. (1993). Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and Von Willebrand factor in patients with Mediterranean Spotted Fever. Blood, 82, 2109-2116.
32. HALPERIN, J.J., WORMSER, G.P. (2001). Of fleas and ticks on cats and mice... Archives of Neurology, 58, 1345-1347.
33. HOLMAN, R.C., PADDOCK, C.D., CURNS, A.T., KREBS, J.W., MCQUISTON, J.H., CHILDS, J.E. (2001). Analysis of risk factors for fatal Rocky Mountain Spotted Fever, evidence for superiority of tetracyclines for therapy. Journal of Infectious Diseases, 184, 1437-1444.
34. HOVE, M.G., WALKER, D.H. (1995). Persistence of rickettsiae in the partially viable gangrenous margins of amputated extremities 5 to 7 weeks after onset of Rocky Mountain spotted fever. Archives of Pathology and Laboratory Medicine, 119, 429-431.
35. HUEBNER, R.J. (1946). Rickettsialpox. A newly recognized rickettsial disease. Public Health Reports, 61, 1605-1614.
36. IKEDA, M., YOSHIDA, S., TSUKAGOSHI, H. (1992). Interferon-γ in cerebrospinal fluid in patients with scrub typhus. Journal of Neurological Sciences, 109, 61-63.
37. IKEDA, M., TAKAHASHI, H., YOSHIDA, S. (1994). HLA-DR+ CD3+ and CD8+ cells are increased but CD4+ CD45RA+ cells are reduced in the peripheral blood in human scrub typhus. Clinical Immunology and Immunopathology, 72, 402-404.
38. ISHII, N., KOMATSU, H., NAKAJIMA, H., TANI, K., SUTO, T. (1989). Imported rickettsial African spotted fever in Japan. British Journal of Dermatology, 120, 701-704.
39. IWASAKI, H., MAHARA, F., TAKADA, N., FUJITA, H., UEDA, T. (2001). Fulminant Japanese spotted fever associated with hypercytokinemia. Journal of Clinical Microbiology, 39, 2341-2343.
40. JERRELLS, T.R., OSTERMAN, J.V. (1982). Role of Macrophages in innate and acquired host resistance to experimental Scrub Typhus infection of inbred mice. Infection and Immunity, 37, 1066-1073.
41. JERRELLS, T.R., GENG, P. (1994). The role of Tumor Necrosis Factor in host defence against Scrub typhus rickettsiae. II. Differential induction of Tumor Necrosis Factor-Alpha production by Rickettsia tshutshugamushi and Rickettsia conorii. Microbiology and Immunology, 38, 713-719.
42. KASS, E.M., SZANIAWSKI, W.K., LEVY, H., LEACH, J., SRINIVASAN, K., RIVES, C. (1994). Rickettsialpox in a New York City Hospital., 1980 to 1989. New England Journal of Medicine, 331, 1612-1617.
43. KASUYA, S., NAGANO, I., IKEDA, T., GOTO, C., SHIMOKAWA, K., TAKAHASHI, Y. (1996). Apoptosis of Lymphocites in Mice induced by infection with Rickettsia tshutshugamushi. Infection and Immunity, 64, 3937-3941.
44. KELLY, P.J. (1991). Reactivity of Rickettsia conorii monoclonal antibodies with four Zimbabwean spotted fever group isolates. South African Journal of Science, 87, 539-541.
45. KOUTTS, J., WALSH, P.N., PLOW, E.F., FENTON, J.W., BOUMA, B.N., ZIMMERMAN, T.S. (1978). Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen and thrombin. Journal of Clinical Investigation, 62, 1255-1260.
46. KOVACOVA, E., KAZAR, J. (2000). Rickettsial diseases and their serological diagnosis. Clinics in Laboratory, 46, 239-245.
47. KRIEG, N.R., HOLT, J.C., Eds. (1984). Bergey's manual of systematic bacteriology, Williams & Wilkins, Baltimore/London.
48. LA ROSA, F. (1982). Saggio di alcuni enzimi serici (MHD., LDH., ICD) in corso di Febbre Bottonosa. Acta Mediterranea di Patologia Infettiva e Tropicale, 1, 419-427. (in italian)
49. LAND, M.V., CHING, W.M., DASCH, G.A., ZHANG, Z., KELLY, D.J., GRAVES, S.R., DEVINE, P.L. (2000). Evaluation of a commercially available recombinant-protein enzyme-linked immunosorbent assay for detection of antibodies produced in scrub typhus rickettsial infections. Journal of Clinical Microbiology, 38, 2701-2705.
50. LI, H. (1987). Gamma Interferon as a crucial host defence against Rickettsia conorii in vivo. Infection and Immunity, 55, 1252-1255.
51. LOMBARDI, R., MANNUCCI, P.M., SEGHATCHIAN, M.J., GARCIA, V.V., COPPOLA, R. (1981). Alteration of Von Willebrand factor in clinical conditions associated with an increase in its plasma concentration. British Journal of Haematology, 49, 61-64.
52. LUTWICK, L.I. (2001). Brill-Zinsser disease. Lancet, 357, 1198-1200.
53. MANDELL, G.L. (1993). Malattie Infettive. Principi e Pratica. Piccin Nuova Libraria, Padova. (in italian)
54. MANSUETO, S. (1971). Moderni orientamenti in tema di epidemiologia e clinica delle rickettsiosi. Il Policlinico Sezione Pratica, 81, 253-260. (in italian)
55. MANSUETO, S. (1975). Sulla etiologia rickettsiosica delle arteriopatie obliteranti croniche. Minerva Cardioangiologica, 23, 599-606. (in italian)
56. MANSUETO, S. (1979). La diagnostica di laboratorio della Febbre Bottonosa. Giornale di Malattie Infettive e Parassitarie, 31, 507-518. (in italian)
57. MANSUETO, S., MICELI, M.D. (1980). ELISA and Rickettsiosis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 70, 831-832.
58. MANSUETO, S., DI LEO, R., CASANDRA, F., MANISCALCO, M. (1982). Unusual pancreatic involvement in a case of mediterranean spotted fever. Tropical Medicine, 34, 268-271.
59. MANSUETO, S. (1983). Studio di alcuni parametri enzimatici in corso di Febbre Bottonosa. II - Comportamento e significato della latticodeidrogenasi. Bollettino dell' Istituto Sieroterapia di Milano, 62, 293-297. (in italian)
60. MANSUETO, S., DI LEO, R., TRINGALI, G. (1983). Unusual abdominal involvement in Rickettsial diseases. Journal of the American Medical Association, 249, 1709-1710.
61. MANSUETO, S., VITALE, G., WALKER, D.H., TRINGALI, G. (1985 a). C-reactive Protein in Boutonneuse Fever. European Journal of Clinical Microbiology, 5, 545-546.
62. MANSUETO, S., VITALE, G., BENTIVEGNA, M., TRINGALI, G., DI LEO, R. (1985 b). Persistence of antibodies to Rickettsia conorii after an acute attack of Boutonneuse Fever. Journal of Infectious Diseases, 151, 377.
63. MANSUETO, S., TRINGALI, G., WALKER, D.H. (1986). Widespread, simultaneous increase in the incidence of Spotted Fever Group Rickettsioses. Journal of Infectious. Diseases, 154, 539-540.
64. MANSUETO, S., TRINGALI, G. (1986). Reperti sperimentali nella infezione da Rickettsia conorii. Giornale di Malattie Infettive e Parassitarie, 38, 1137-1151. (in italian)
65. MANSUETO, S., VITALE, G. (1986). Isolamento di R.conorii da pazienti con Febbre Bottonosa. Acta Mediterranea di Patologia Infettiva e Tropicale, 5, 433-435. (in italian)
66. MANSUETO, S., VITALE, G., MOCCIARO, C., LIBRIZZI, R., FRISCIA, I., USTICANO, V., GAMBINO, G., REINA, G. (1989). Laboratory diagnosis of Boutonneuse Fever by enzyme-linked-immunosorbent-assay. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 855-857.
67. MANSUETO, S., VITALE, G., CILLARI, E., MOCCIARO, C., GAMBINO, G., PICCIONE, E., BUSCEMI, S., ROTONDO, G. (1994). High levels of interferon-γ in Boutonneuse Fever. Journal of Infectious Diseases, 170, 1637-1638.
68. MANSUETO, S. (1996). Febbre bottonosa. In: A. Notarbartolo (Ed.), Medicina Clinica, Grasso, Bologna, 2: 2001-2004. (in italian)
69. MANSUETO, S., D'ANCONA, F.P., COLLETTI, P., GRACEFFA, R., LA SETA, F., PECORARO, V., GAMBINO, G., GRILLO, G., VITALE, G., RICHIUSA, P., D'AGOSTINO, P., CILLARI, E. (1997). Alteration of Interleuchin-2 (IL-2) and soluble IL-2 receptor in the sera and urine of patients with rickettsial Boutonneuse Fever. Journal of Infectious Diseases, 175, 142-145.
70. MARGOLIUS, H.S. (1995). Kallikreins and kinins. Some unanswered questions about system characteristics and roles in human disease. Hypertension, 26, 221-229.
71. MARSCHANG, G.A., NOTHDURFT, H.D., KUMLIEN, S., VON SONNENBURG, F. (1995). Imported rickettsioses in German travelers. Infection, 23, 94-97.
72. MATHAI, E., LLOYD, G., CHERIAN, T., ABRAHAM, O.C., CHERIAN, A.M. (2001). Serological evidence for the continued presence of human rickettsioses in southern India. Annals of Tropical Medicine and Parasitology. 95, 395-398.
73. MCDADE, J. (2000). New and emerging pathogens. International Journal of Clinical Practice, Suppl. 115, 55-59.
74. MCDONALD, J.C., MACLEAN, J.D., MCDADE, J.E. (1988). Imported rickettsial diseases, clinical and epidemiological features. American Journal of Medicine, 83, 799-805.
75. MCORIST, S. (2000). Obligate intracellular bacteria and antibiotic resistance. Trends in Microbiology, 8, 483-486.
76. MEKHLOUFI, E.Y., AIT-ABBAS, N. (2001). Mediterranean spotted fever complicated by myocarditis. Presse Medicine, 30, 586,
77. MELTZER, M.S., NACY, C.A. (1980). Macrophages in resistance to rickettsial infection, susceptibility to lethal effects of Rickettsia akari infection in mouse strains with defective macrophage function. Cellular Immunology, 54, 487-490.
78. MILANO, S., D'AGOSTINO, P., DI BELLA, G., LA ROSA, M., BARBERA, C., FERLAZZO, V., MANSUETO, P., RINI, G.B., BARERA, A., VITALE, G., MANSUETO, S., CILLARI, E. (2000). Interleukin-12 in human boutonneuse fever-caused by Rickettsia conorii. Scandinavian Journal of Immunology, 52, 91-95.
79. MIRAGLIOTTA, G. (1981). Platelet aggregation and stimulation of leucocyte procoagulant activity by rickettsial lipopolysacharides in rabbits and in man. Experientia, 37, 47-49.
80. MOE, J.B., MOSHER, D.F., KENYON, R.H., WHITE, J.D., STOOKEY, J.L., BAGLEY, L.R., FINE, D.P. (1976). Functional and morphologic changes during experimental Rocky Mountain spotted fever in guinea pigs. Laboratory Investigation, 35, 235-245.
81. MONTENEGRO, M.R. (1983 a). The histology of "tache noires" of boutonneuse fever and demonstration of Rickettsia conorii in them by immunofluorescence. Virchows Archives, 400, 309-317.
82. MONTENEGRO, M.R. (1983 b). Identification of Rickettsia conorii in tissue by immunofluorescence. Acta Mediterranea di Patologia Infettiva e Tropicale, 2, 161-168.
83. NILSSON, K., LINDQUIST, O., PAHLSON, C. (1999). Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death. Lancet, 354, 1169-1173.
84. OLIVEIRA, J., CORTE-REAL, R. (1999). Rickettsia infections in Portugal. Acta Medica du Portugal, 12, 313-321.
85. ORISTRELL, J., AMENGUAL, M.J., FONT-CREUS, B., CASANOVAS, A., SEGURA-PORTA, F. (1994). Plasma levels of Tumor Necrosis Factor-αin patients with spotted fever, clinical and analytical correlations. Clinical Infectious Diseases, 19: 1141-1142.
86. PALMER, B.A., HETRICK, F.M., JERRELLS, T.J. (1984). Production of gamma interferon in mice immune to Rickettsia tsutsugamushi. Infection and Immunity, 43: 59-65.
87. PERALTA, S. (1991 a). The treatment of Boutonneuse Fever, state of the art. Journal of Chemoterapy, 3, 456.
88. PERALTA, S. (1991 b). Two new therapeutic drugs for Boutonneuse fever with the traditional ones (Pefloxacine and ciprofloxacine versus thiamphenicol and doxycycline). Therapy of Infectious Diseases, 3, 255.
89. PERALTA, S. (1995). Epidemiological and clinical features of Boutonneuse fever in Italy in the last 13 years. Annali Italiani di Medicina Interna, 10, 62-63.
90. PIEMONT, Y., BERMOND, D. (2001). Infections caused by Bartonella spp. Annals of Biological Clinica, 59, 593-604.
91. PIRAS, M.A., CALIA, G., SABA, F., GAKIS, C., ANDREONI, G. (1983). Glucose-6-phosphate deydrogenase deficiency in male patients with Mediterranean spotted fever in Sardinia. Journal of Infectious Diseases, 147, 607-608.
92. PRETORIUS, A.M., KELLY, P.J. (2000). An update on human ehrlichioses. Central African Journal Medicine, 46, 277-282.
93. PURVIS, J.J., EDWARDS, M.S. (2000). Doxycycline use for rickettsial disease in pediatric patients. Pediatric Infectious Disease Journal, 19, 871-874.
94. RAO, A.K., SCHAPIRA, M., CLEMENTS, M.L., NIEWIAROWSKI, S., BUDZYNSKI, A.Z., SCHMAIER, A.H., HARPEL, P.C., BLACKWELDER, W.C., SCHERRER, J.R., SOBEL, E. (1988). A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. New England Journal of Medicine, 318, 1021-1028.
95. RAOULT, D., BROUQUI, P., ROUX, V. (1996). A new spotted-fever-group Rickettsiosis. Lancet, 348, 412.
96. RICHARDS, A.L., MALONE, J.D., SHERIS, S., WEDDLE, J.R., ROSSI, C.A., KSIAZEK, T.G., LEDUC, J.W., DASCH, G.A., HYAMS, K.C. (1993). Arbovirus and Rickettsial infections among Combat Troops during operation Desert Shield/Desert Storm. Journal of Infectious Diseases, 168, 1080-1081.
97. ROLAIN, J.M., MAURIN, M., VESTRIS, G., RAOULT, D. (1998). In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials. Antimicrobial Agents Chemotherapy, 42, 1537-1541.
98. ROLLWAGEN, F.M. (1988). Role of natural killer cells in the early clearance of Rickettsia typhi in mice. Advances in Experimental Medicine and Biology, 239, 163-168.
99. RYDKINA, E., ROUX, V., RUDAKOV, N., GAFAROVA, M., TARASEVICH, I., RAOULT, D. (1999). New Rickettsiae in ticks collected in territories of the former soviet union. Emerging Infectious Diseases, 5, 811-814.
100. SCAFFIDI, A. (1977). Recenti osservazioni di Febbre Bottonosa nella Sicilia Occidentale. Minerva Medica, 68, 2373-2376. (in italian).
101. SCAFFIDI, A. (1981). Compromissione e complicanze cardiovascolari nella FB mediterranea. Minerva Medica, 72, 2097-2108. (in italian).
102. SCAFFIDI, L., FERRIGNO, V. (1981). Rilievi e considerazioni sulla "tache noire" nella Febbre Bottonosa. Minerva Medica, 72, 2079-2084. (in italian).
103. SCAFFIDI, L., MANSUETO, S. (1981). La febbre bottonosa nella pratica clinica. Minerva Medica, 72, 2071-2078. (in italian).
104. SCAFFIDI, L., SCAFFIDI, A. (1981). Rilievi e considerazioni sul rash della Febbre Bottonosa mediterranea. Minerva Medica, 72, 2085-2096. (in italian)
105. SCAFFIDI, V. (1951). Il tifo esantematico di genesi murina. Idelson, Napoli. (in italian).
106. SCAFFIDI, V., MANSUETO, S., SCAFFIDI, L. (1977). Intra-infectious vasculitis and late sequelae of rickettsiosis. Minerva Medica, 68, 2413-2426. (in italian).
107. SCAFFIDI, V. (1982). Febbre Bottonosa e turismo. Minerva Medica, 73, 1781-1785. (in italian).
108. SCHAFFNER, W., STANDAERT, S.M. (1996). Ehrlichiosis. In pursuit of an emerging infection. New England Journal of Medicine, 334, 262-263.
109. SCHRIEFER, M.E., SACCI, J.B., DUMLER, J.S., BULLEN, M.G., AZAD, A.F. (1994). Identification of a novel rickettsial infection in a patient diagnosed with murine typhus. Journal of Clinical Microbiology, 32, 949-954.
110. SEKEYOVA, Z., ROUX, V., RAOULT, D. (2001). Phylogeny of Rickettsia spp. inferred by comparing sequences of 'gene D'., which encodes an intracytoplasmic protein. International Journal of Systematic and Evolutionary Microbiology, 51, 1353-1360.
111. SHER, A., GAZZINELLI, R.T., OSWALD, I.P., CLERICI, M., KULLBERG, M., PEARCE, E.J., BERZOFSKY, J.A., MOSMANN, T.R., JAMES, S.L., MORSE, H.C. (1992). Role of T-cell derived cytokines in the down-regulation of immune responses in parasitic and retroviral infection. Immunology Reviews, 127, 183-204.
112. SILVERMAN, D.J., BOND, S.B. (1984). Infection of human vascular endothelium cells by Rickettsia conorii. Journal of Infectious Diseases, 149, 201-206.
113. SILVERMAN, D.J. (1984). Rickettsia rickettsii-induced cellular injury of human vascular endothelium in vitro. Infection and Immunity, 44, 545-53.
114. SILVERMAN, D.J. (1986). Adherence of platelets to human endothelial cells infected by Rickettsia rickettsii. Journal of Infectious Diseases, 153, 694-700.
115. SPORN, L.A., SHI, R.J., LAWRENCE, S.O., SILVERMAN, D.J., MARDER, V.J. (1991). Rickettsia rickettsii infection of cultured endothelial cells induces release of large vWF multimers from Weibel-Palade bodies. Blood, 78, 2595-2602.
116. STAITI, A., PARATORE, A. (1981). Aspetti clinici delle rickettsiosi esantematiche, interessamento miocardico e meningeo. Rivista di Parassitologia, 12, 431-433. (in italian)
117. STAITI, A. (1982). Latticodeidrogenasi e piastrine nella Febbre Bottonosa. Acta Mediterranea di Patologia Infettiva e Tropicale, 1, 167-173. (in italian)
118. STEIN, J.H. (1995). Medicina Interna, Betagraf, Bologna. (in italian).
119. STENOS, J., WALKER, D.H. (2000). The rickettsial outer-membrane protein A and B genes of Rickettsia australis, the most divergent rickettsia of the spotted fever group. International Journal of Systematic and Evolutionary Microbiology, 50, 1775-1779.
120. TAEGE, A.J. (2000). Tick trouble, overview of tick-borne diseases. Cleveland Clinical. Journal of Medicine, 241, 245-249.
121. TREADWELL, T.A., HOLMAN, R.C., CLARKE, M.J., KREBS, J.W., PADDOCK, C.D., CHILDS, J.E. (2000). Rocky Mountain spotted fever in the United States, 1993-1996. American Journal of Tropical Medicine and Hygien, 63, 21-26.
122. TRINGALI, G. (1985). Manifestazioni extracutanee nelle malattie da R. rickettsi ed R. conorii. Giornale di Malattie Infettive e Parassitarie, 37, 161-163. (in italian).
123. TRINGALI, G. (1986). Dimostrazione diretta di R. conorii in cavie e cotton rat sperimentalmente infettati. Acta Mediterranea di Patologia Infettiva e Tropicale, 5, 51-56. (in italian)
124. VICENTE, V., ALBERCA, I., RUIZ, R., HERRERO, I., GONZALEZ, R., PORTUGAL, J. (1986 a). Coagulation abnormalities in patients with spotted fever. Journal of Infectious Diseases, 153, 128-131.
125. VICENTE, V. (1986 b). Kinin-Prekallikrein System in Mediterranean Spotted Fever. Journal of Infectious Diseases, 154, 541.
126. VITALE, G., DI STEFANO, R., DAMIANI, G., MANSUETO, S. (1989 a). Characterization of Sicilian strains of spotted fever group rickettsiae by using monoclonal antibodies. Journal of Clinical Microbiology, 27, 1081-1085.
127. VITALE, G., DI STEFANO, R., DAMIANI, G., MANSUETO, S. (1989 b). Antibiotic susceptibility of Sicilian strains of rickettsia. Journal of Chemoterapy, S4, 352-53.
128. VITALE, G., MANSUETO, S., GAMBINO, G., MOCCIARO, C., SPINELLI, A., RINI, G.B., AFFRONTI, M., CHIFARI, N., LA RUSSA, C., DI ROSA, S., COLLETTI, P., BARBERA, C., LA ROSA, M., DI BELLA, G., FERLAZZO, V., MILANO, S., D'AGOSTINO, P., CILLARI, E. (2001). The acute phase response in Sicilian patients with boutonneuse fever admitted to hospitals in Palermo., 1992-1997. Journal of Infection, 42, 33-39.
129. WALKER, D.H., HARRISON, A., HENDERSON, F., MURPHY, F.A. (1978). Specific diagnosis of Rocky Mountain spotted fever by immunofluorescent demonstration of Rickettsia rickettsii in cutaneous lesions. American Journal of Clinical Pathology, 69, 619-623.
130. WALKER, DH., MATTERN, WD. (1980). Rickettsial vasculitis. American Hearth Journal, 100, 896-906.
131. WALKER, D.H., GAY, R.M., VALDES-DAPENA, M. (1981). The occurrence of eschars of Rocky Mountain Spotted Fever. Journal of the American Academy of Dermatology, 4, 571-576.
132. WALKER, D.H., HAWKINS, H.K., HUDSON, P. (1983). Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate deydrogenase deficiency. Archives of Pathology and Laboratory Medicine, 107, 121-125.
133. WALKER, D.H., GEAR, J.H.S. (1983). Correlation of distribution of R.conorii, microscopic lesions and clinical features in South African tick bite fever. American Journal of Tropical Medicine and Hygien, 34, 361-371.
134. WALKER, DH. (1984). Rickettsial interactions with human endothelial cells in vitro, adherence and entry. Infection and Immunity, 44, 205-210.
135. WALKER, D.H., OCCHINO, C., TRINGALI, G.R., DI ROSA, S., MANSUETO, S. (1988). Pathogenesis of rickettsial eschars, the tache noire in boutonneuse fever. Human Pathology, 19, 1449-1454.
136. WALKER, D.H., PARKS, F.M., BETZ, T.G., TAYLOR, J.P., MUEHLBERGER, J.W. (1989). Histopathology and immunohistologic demonstration of the distribution of Rickettsia typhi in fatal murine typhus. American Journal of Clinical Pathology, 91, 720-724.
137. Walker, D.H. (1989). Rickettsioses of Spotted Fever Group around the World. Journal of Dermatology, 16, 169-177.
138. WALKER, T.S., BROWN, J.S., HOOVER, C.S., MORGAN, D.A. (1990). Endothelial prostaglandin secretion, effects of Typhus Rickettsiae. Journal of Infectious Diseases, 162, 1136-1144.
139. WALKER, D.H., DUMLER, J.S. (1996). Emergence of the Ehrlichioses as Human Health Problems. Emerging Infectious Diseases, 2, 18-29.
140. WALKER, D.H., OLANO, J.P., FENG, H.M. (1997). Identification of Rickettsia rickettsii in a guinea pig model by immunofluorescent and electron microscopic tecniques. American Journal of Pathology, 86, 343-348.
141. WALKER, D.H., HUDNALL, S.D., SZANIAWSKI, W.K., FENG, H.M. (1999). Monoclonal antibody-based immunohistochemical diagnosis of rickettsialpox, the macrophage is the principal target. Modern Pathology, 12, 529-533.
142. WALKER, D.H., POPOV, V.L., FENG, H.M. (2000). Establishment of a novel endothelial target mouse model of a typhus group rickettsiosis, evidence for critical roles for gamma interferon and CD8 T lymphocytes. Laboratory Investigation, 80, 1361-1372.
143. WALKER, D.H., OLANO, J.P., FENG, H.M. (2001). Critical role of cytotoxic T lymphocytes in immune clearance of rickettsial infection. Infection and Immunity, 69, 1841-1846.
144. WESTERMAN, E.L. (1982). Rocky Mountain spotless fever, a dilemma for the clinician. Archives of Internal Medicine, 142, 1106-1107.
145. WOODWARD, T.E., PEDERSEN, C.E., OSTER, C.N., BAGLEY, L.R., ROMBERGER, J., SNYDER, M.J. (1976). Prompt confirmation of Rocky Mountain Spotted Fever, identification of Rickettsia in skin tissues. Journal of Infectious Diseases, 134, 297-301.
146. WOODWARD, T.E. (1995). Rickettsial diseases. In: Harrison's Principles of Internal Medicine. Thirteenth edition, McGaw-Hill, New York, NY, p. 747-757.
147. YAMADA, T., HARBER, P., PETTIT, G.W., WING, D.A., OSTER, C.N. (1978). Activation of the kallikrein-kinin system in Rocky Mountain Spotted Fever. Annals of Internal Medicine, 88, 764-768.
148. YU, X., JIN, Y., FAN, M., XU, G., LIU, Q., RAOULT, D. (1993). Genotypic and antigenic identification of two new strains of spotted fever group rickettsiae isolated from China. Journal of Clinical Microbiology, 31, 83-88.
149. ZDDROVSKII, P.F., GOLINEVICH, H.M. (1960). The rickettsial diseases. Pergamon Press, New York.
150. ZECHINI, F. (1977). Osservazioni epidemiologiche, cliniche e terapeutiche su 50 casi di Rickettsia conorii. Minerva Medica, 68, 2387-2392. (in Italian).